Navigation Links
New Clinical Trial Results Could Improve Survival for Myeloma Patients

The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians// - today said physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.

High dose dexamethasone has been used as standard therapy for the treatment of myeloma alone and in combination with other drugs. However, interim findings from a large ongoing clinical trial of REVLIMID plus dexamethasone in newly diagnosed patients, suggest lowering the "dex" dose may not only reduce side effects, but also may improve survival.

The trial, known as E4A03, is sponsored by the National Cancer Institute and led by the Eastern Cooperative Oncology Group (ECOG). Based on these findings, ECOG has suspended further patient enrollment for this trial and has recommended that lower dose "dex" be considered for patients currently being treated on the high dose arm of the trial. Because of the public health implications, these findings are being made public immediately. The complete details will be presented at a cancer conference later this spring.

"Improved survival with low dose 'dex' and REVLIMID is an important finding because it further improves the outcome for an already successful treatment, while low dose dexamethasone is better tolerated by patients," said Brian G. M. Durie, M.D., chairman and co-founder of the International Myeloma Foundation. "We are recommending that physicians consider these findings when treating their patients across all stages of myeloma and that patients discuss these findings with their physicians."

Susie Novis, president and co-founder of the IMF, added, "These findings may also have wider implications for cancer treatments because they challenge the traditional notion that patients should be treated with the highest dose of medicine they can tolerate. Now we have evidence that
'"/>




Page: 1 2 3

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Renal Trails Do Not Have Sufficient Women Participants
7. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
8. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
9. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
10. Cancer Clinical Research in India
11. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
Post Your Comments:
(Date:8/3/2015)... ... ... A July 9 article from USA Today has revealed a ... American Dental Association. According to a study by the American Dental Association, from 2000 ... single year to 2.2 million a year. Dentists and ADA officials all point to ...
(Date:8/3/2015)... ... ... Dignity Health named Dr. Norris A. Baldwin, Jr. the Facility Medical Director of ... The new facility is licensed under Dignity Health Arizona General Hospital , ... an excellent leader and will ensure our new freestanding emergency room delivers the highest ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Foot ... of a new associate podiatrist, creating the largest medical practice in the Mid-Atlantic region ... ankle medicine. FASMA operates 21 locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is ...
(Date:8/3/2015)... Louisville, KY (PRWEB) , ... August 03, 2015 , ... ... suffer from lower back pain at least once in their lives. Often time, low ... bulges. Until recently, disc herniations could only be managed clinically with powerful pain medication ...
(Date:8/2/2015)... ... August 02, 2015 , ... ... and connective tissues of a woman’s pelvic organs (uterus, bladder, and bowel) ... heavy lifting, obesity, constipation, multiple vaginal deliveries, genetics, smoking, and the aging ...
Breaking Medicine News(10 mins):Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Dynamic Health Care in Louisville, KY, Offers a New and Cutting-Edge Therapy for Low Back & Leg Pain Sufferers 2Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2
... a statement released by Ranbaxy Pharmaceuticals Inc (RPI), they ... Award // from Wal-Mart, the largest chain store in ... of 2005. Wal-Mart Stores is a global company with ... stores and wholesale clubs across 10 countries. , ...
... cells that are responsible for causing epileptic seizures // ... of Medicine have identified glutamate receptor cells in the ... of glutamate when there is brain action that’s associated ... that will affect the protective glutamate receptors in increasing ...
... University of Michigan, who had long earlier published their findings ... ADHD, have come up with the results from the next ... the two. ,The follow up data of the ... who had snored regularly through their childhood are four times ...
... Cancer Institute and collaborating institutions have found sections of ... genes may lurk. , ,In a study ... Research, the researchers used single nucleotide polymorphism (SNP) array ... genes, to identify regions of chromosomes where genes were ...
... Vaccines for prophylaxis are well known. Famous vaccines include ... etc.; Therapeutic vaccines to cure a condition are more ... include the ones against HIV and hepatitis. The therapeutic ... combat an infectious agent, such as a virus. Now ...
... Statins are known to successfully treat atherosclerosis, the narrowing ... whether the drugs could also treat a similar condition ... valve in the heart. , ,According to a ... high doses of cholesterol-lowering drugs actually fail to treat ...
Cached Medicine News:Health News:Possible location of lung cancer genes found 2Health News:Understanding Chronic Infections May Help in Developing Therapeutic Vaccines 2
(Date:8/3/2015)... 3, 2015  EnteroMedics Inc. (NASDAQ: ETRM ), the ... obesity, metabolic diseases and other gastrointestinal disorders, today announced ... to the Board of Directors, effective July 31, 2015.  ... until the 2018 annual meeting or until her successor ... served in an executive capacity in the healthcare industry ...
(Date:8/2/2015)... , August 3, 2015 ... Dechra Pharmaceuticals PLC ("Dechra" or the "Company") is ... purchase agreement ("SPA") with Mr. Marijan Han žeković ... rights) in Genera d.d. ("Genera"), a Croatian listed pharmaceutical ... per share, which is equivalent to €51.4 million for ...
(Date:7/31/2015)... , July 31, 2015  Seeger Weiss LLP is ... (FDA) issued a warning letter to C.R. Bard, the manufacturer ... taking adequate strides to correct violations the agency found at ... these violations after the FDA cited them during Inspectional Observations ... in Bard,s Tempe, AZ , location and ...
Breaking Medicine Technology:EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3
... International Corporation (NASDAQ: PRXL ) announced today ... Conference in Boston, MA.  Josef von Rickenbach, Chairman and ... PAREXEL at 3:30 p.m. ET on Monday, March 5, 2012. ... presenting at the Raymond James Investors Conference in Orlando, ...
... ReportsnReports adds new market research report , ... and Market Forecasts to 2018 , to its ... $1,412.8m by 2018 growing at a CAGR of 5%. The ... for minimally invasive procedures and technology advances that make surgery ...
Cached Medicine Technology:PAREXEL International to Present at Cowen Healthcare Conference and Raymond James Investors Conference 2Electrosurgical Devices Market to Grow at a CAGR of 5% Globally From 2011-2018 2Electrosurgical Devices Market to Grow at a CAGR of 5% Globally From 2011-2018 3Electrosurgical Devices Market to Grow at a CAGR of 5% Globally From 2011-2018 4
... new 4351 Intramuscular Lead is a unipolar lead ... 4351 lead has a ski needle design for ... designed with a fixed electrode length of 1 ... neurostimulator and is available in 35 cm length. ...
... AwareTM HIV-1/2 OMT test is a single ... for the,detection of antibodies to Human Immunodeficiency ... (HIV-2) in human oral,mucosal transudate specimens. It ... aid in the clinical diagnosis of HIV,infection. ...
... control available with intact red blood cells ... the lysing of the red blood cell. ... with an open-vial stability of 30 days ... when refrigerated. A1c-Cellular is appropriate for immunoassay ...
...
Medicine Products: